Ignite Creation Date:
2025-12-25 @ 12:26 AM
Ignite Modification Date:
2026-03-01 @ 5:53 PM
Study NCT ID:
NCT02366858
Status:
WITHDRAWN
Last Update Posted:
2017-02-14
First Post:
2014-01-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures
Sponsor:
AdventHealth
Organization:
Study Overview
Official Title:
Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures
Status:
WITHDRAWN
Status Verified Date:
2017-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
PI decision was made to discontinue the study
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators hypothesis is that a 22 gauge needle can yield core tissue, obviating the need to use the 19 gauge needle for core tissue procurement.
Detailed Description:
Inclusion Criteria
1. Age under 19 years
2. Pregnant women will be excluded. This will be confirmed by self-report
Exclusion Criteria
1. Age under 19 years
2. Pregnant women will be excluded. This will be confirmed by self-report
1. Age under 19 years
2. Pregnant women will be excluded. This will be confirmed by self-report
Exclusion Criteria
1. Age under 19 years
2. Pregnant women will be excluded. This will be confirmed by self-report
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: